Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

William S. Harris, Michael Miller, Ann P. Tighe, Michael H. Davidson, Ernst J. Schaefer

Research output: Contribution to journalReview articlepeer-review

444 Scopus citations


The most common omega-3 fatty acids contain 18-22 carbons and a signature double bond at the third position from the methyl (or n, or omega) end of the molecule. These fatty acids must be obtained in the diet as they cannot be synthesized by vertebrates. They include the plant-derived α-linolenic acid (ALA, 18:3n-3), and the fish-oil-derived eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). Normally, very little ALA is converted to EPA, and even less to DHA, and therefore direct intake of the latter two is optimal. EPA and DHA and their metabolites have important biologic functions, including effects on membranes, eicosanoid metabolism, and gene transcription. Studies indicate that the use of fish oil is associated with coronary heart disease risk reduction. A number of mechanisms may be responsible for such effects. These include prevention of arrhythmias as well as lowering heart rate and blood pressure, decreasing platelet aggregation, and lowering triglyceride levels. The latter is accomplished by decreasing the production of hepatic triglycerides and increasing the clearance of plasma triglycerides. Our focus is to review the potential mechanisms by which these fatty acids reduce cardiovascular disease risk.

Original languageEnglish (US)
Pages (from-to)12-24
Number of pages13
Issue number1
StatePublished - Mar 2008
Externally publishedYes


  • Arrhythmia
  • Coronary heart disease
  • Omega-3 fatty acids
  • Platelet aggregation
  • Triglyceride

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives'. Together they form a unique fingerprint.

Cite this